ARTICLE | Clinical News
Faropenem medoxomil regulatory update
October 30, 2006 8:00 AM UTC
Replidyne Inc. (RDYN), Louisville, Colo. Forest Laboratories Inc. (FRX), New York, N.Y. Product: Faropenem medoxomil Business: Infectious RDYN received a not approvable letter from FDA for faropenem,...